BACKGROUND: There is a continuous interest in the literature concerning the management and survival after treatment of local recurrence in sarcomas because it is one of the most common types of recurrence. DESIGN: We retrospectively reviewed 93 patients treated for local recurrence from soft-tissue sarcoma. METHODS: We evaluated prognostic parameters (grade, tumor size, location) and the effect of treatment on survival. RESULTS: Resection of all the gross tumor at first visit to our Institute for local recurrence was accomplished in 88 patients (95%). Of the 59 patients with extremity tumors, six (10%) required an amputation. At a mean follow-up of 66 months, further local recurrence was noted in 27%. The estimated 5-year survival rate was 100% for patients with grade I tumors (n = 16), 77% for grade II (n = 31), and 45% for grade III tumors (n = 46) (p = 0.0002). This value was 78% for tumors < or = 5 cm and 57% for those > 5 cm (p = 0.03). CONCLUSIONS: Local recurrence is resectable and limb preservation is possible in the majority of patients. The overall 5-year survival rate was 65%. Survival after treatment of local recurrence is determined mainly by the grade and secondarily by the size of the tumor as for primary sarcomas.
BACKGROUND: There is a continuous interest in the literature concerning the management and survival after treatment of local recurrence in sarcomas because it is one of the most common types of recurrence. DESIGN: We retrospectively reviewed 93 patients treated for local recurrence from soft-tissue sarcoma. METHODS: We evaluated prognostic parameters (grade, tumor size, location) and the effect of treatment on survival. RESULTS: Resection of all the gross tumor at first visit to our Institute for local recurrence was accomplished in 88 patients (95%). Of the 59 patients with extremity tumors, six (10%) required an amputation. At a mean follow-up of 66 months, further local recurrence was noted in 27%. The estimated 5-year survival rate was 100% for patients with grade I tumors (n = 16), 77% for grade II (n = 31), and 45% for grade III tumors (n = 46) (p = 0.0002). This value was 78% for tumors < or = 5 cm and 57% for those > 5 cm (p = 0.03). CONCLUSIONS: Local recurrence is resectable and limb preservation is possible in the majority of patients. The overall 5-year survival rate was 65%. Survival after treatment of local recurrence is determined mainly by the grade and secondarily by the size of the tumor as for primary sarcomas.
Authors: D A Potter; J Glenn; T Kinsella; E Glatstein; E E Lack; C Restrepo; D E White; C A Seipp; R Wesley; S A Rosenberg Journal: J Clin Oncol Date: 1985-03 Impact factor: 44.544
Authors: D A Potter; T Kinsella; E Glatstein; R Wesley; D E White; C A Seipp; A E Chang; E E Lack; J Costa; S A Rosenberg Journal: Cancer Date: 1986-07-01 Impact factor: 6.860
Authors: Alexandra M Koenig; Matthias Reeh; Christoph M Burdelski; Claudia Wengert; Karim A Gawad; Jakob R Izbicki; Maximilian Bockhorn Journal: Langenbecks Arch Surg Date: 2012-03-10 Impact factor: 3.445
Authors: Gregory G Kolovich; Adam N Wooldridge; Jonathan M Christy; Martha K Crist; Joel L Mayerson; Thomas J Scharschmidt Journal: Med Oncol Date: 2011-05-07 Impact factor: 3.064
Authors: Sarantis Abatzoglou; Robert E Turcotte; Abdurahman Adoubali; Marc H Isler; David Roberge Journal: Clin Orthop Relat Res Date: 2010-11 Impact factor: 4.176
Authors: Fritz C Eilber; Gerald Rosen; Scott D Nelson; Michael Selch; Frederick Dorey; Jeffery Eckardt; Frederick R Eilber Journal: Ann Surg Date: 2003-02 Impact factor: 12.969